Summary A study of 953 invasive cutaneous malignant melanomas of the head and neck was performed to determine differences between lentigo maligna melanoma and other histogenetic types with regard to patients and sites affected; prognosis was analysed in 595 of these cases. The cases studied comprised all head and neck melanomas registered with the Scottish Melanoma Group between 1979 and 1992, apart from the 3% of cases that were unclassifiable or rare histogenetic types. The histogenetic types of melanoma were 498 (52%) lentigo maligna melanoma (LMM), 237 (25%) superficial spreading melanoma (SSM) and 218 (23%) nodular melanoma (NM). All types increased in incidence throughout the study period. Patients with LMM (mean age 73 years) and NM (mean 68 years) were significantly older than those with SSM (mean 57 years). There were significant anatomical subsite differences related to sex of patients and histogenetic type of melanoma; melanomas on the face were more frequent in females and 90% of LMM occurred at this site, whereas melanomas on the scalp, neck and ears were more frequent in men. Kaplan-Meier estimates of the probability of survival were produced for the 595 of these 953 patients with 5 year follow-up details. In this group of patients the prognostic significance of tumour thickness, Clark level of invasion, ulceration, histogenetic type of melanoma and number of mitoses were studied using stepwise variable selection of procedures. Each of these possible prognostic factors attained individual significance but the tumour thickness was the dominant risk factor in the proportional hazards analysis. When patients were divided into four sex/ulceration subgroups (male/ulcerated, female/ulcerated, male/non-ulcerated, female/non-ulcerated) and analysed by proportional hazards analysis, no variable other than the tumour thickness had any further prognostic effect. Histogenetic type did not remain an independent prognostic variable at this stage. Despite sex and subsite differences, the prognosis for invasive lentigo maligna melanoma does not differ from that for other histogenetic types after controlling for tumour thickness.
In Caucasians, about 10-20% of all malignant melanomas occur on the head and neck (McGovern et al., 1980; Sober et al., 1980; MacKie et al., 1985; Cox et al., 1987; Fisher, 1989; O'Brien et al., 1991; Langford et al., 1993) , and therefore comprise a numerically important subset of a malignancy that has shown increasing incidence over several decades in most populations worldwide. Malignant melanoma of the head and neck has some notable differences from those at other body sites, especially a higher frequency of the lentigo maligna type of melanoma (McGovern et al., 1980; Sober et al., 1980; MacKie et al., 1985; Cox et al., 1987; Fisher, 1989; Langford et al., 1993) . From a management point of view, an important difference compared with other sites is that excision margins of thicker malignant melanomas of the head and neck may be limited by functional or cosmetic considerations.
Although tumour thickness (Breslow, 1970) at these, as at other sites, is accepted as a major prognostic factor, there is some variation between studies regarding other prognostic factors. One specific important question that remains is whether the prognosis for lentigo maligna melanoma differs significantly from the prognosis for melanoma of other histogenetic types. Many of the larger studies have originated from selected populations treated at tertiary referral centres in countries with high levels of sun exposure (Conley and Pack, 1963; Ballantyne, 1970; McGovern et al., 1980; Gussack et al., 1983; Urist et al., 1984; Fisher, 1989; O'Brien et al., 1991; Langford et al., 1993) . We have therefore studied the clinicopathological features of 953 malignant melanomas of the head and neck registered with the Scottish Melanoma Group (SMG) between 1979 and 1992 inclusive. These comprise all cases of head and neck melanoma diagnosed in Scotland over this 14 year period and are therefore a valuable database for population-based epidemiology. To clarify prognostic issues discussed in an earlier study (Cox et al., 1987) , we have analysed prognostic factors in the 595 cases in this database for whom follow-up data was available until at least the fifth year after diagnosis (all cases 1979-86).
Methods
Details of 953 patients with clinical stage I invasive malignant melanoma of the head and neck were available. These comprised the 97% of cases of invasive malignant melanoma of the three main histogenetic types at this body site that had been registered with the Scottish Melanoma Group from 1979 to 1992 (the other 3% were melanomas of unclassifiable histogenetic type); patients with non-invasive lentigo maligna or intraepidermal (Clark level I) in situ malignant melanoma were excluded. Registration methods have been described in detail elsewhere (MacKie et al., 1985) . The registrations, to the best of our knowledge, comprise all malignant melanomas occurring in the population (5 million persons) in Scotland, and are updated by contacting the responsible clinician periodically for details of outcome.
The factors that were considered comprised age and sex of patients, histogenetic type of melanoma, and anatomical subsite affected (face, scalp, neck, ears Kaplan-Meier estimates of the probability of survival were used to describe the survival profiles, and the effects of the potential prognostic risk factors were studied using logrank tests and proportional hazards modelling, which involved forward stepwise and backward elimination variable selection procedures (Everitt, 1989 
Results
Incidence by histogenetic type All histogenetic types of malignant melanoma of the head and neck increased in incidence over the period studied ( Figure 1 ). Malignant melanoma at this site accounted for 21% of the total number of registrations for all body sites; lentigo maligna melanoma (LMM) on the head and neck accounted for 83% of all cases of LMM. The proportions of the different histogenetic types (see Table I for absolute values) were: LMM 52%, superficial spreading melanoma (SSM) 25%, nodular melanoma (NM) 23%.
Age and sex related to histogenetic type There were significant differences among histogenetic types relating to the age of patients (Table I) . Patients with LMM or with NM were significantly older than those with SSM (both P<0.0001, Wilcoxon-Mann-Whitney test); those with LMM were older than those with NM but this was not statistically significant. The ratio of females to males for each histogenetic type was LMM 1.74:1, SSM 1.24:1, NM 0.98:1 (Table I ). For each of these histogenetic types, the mean age for female patients was 2-3 years greater than that for males (not statistically significant). with the other subtypes in isolation, but 63% of these were less than 1.5 mm thick and therefore expected to have a good prognosis. As will be seen below, histogenetic type did not remain an independent prognostic factor when a stepwise proportional hazards model was used. The individual significance of each of the possible prognostic risk factors was statistically assessed (Table III) , demonstrating that prognosis was significantly related to each of the following in isolation: sex of patients, histogenetic type of melanoma, presence of ulceration, tumour thickness, Clark level of invasion and level of mitotic activity. A stepwise proportional hazards analysis was performed, which demonstrated (Table III) that tumour thickness was clearly the dominant risk factor. Male sex, ulceration and deep invasion (level 5) all had a significant adverse effect after controlling for thickness and for each other. LMM had a better prognosis when compared with NM and SSM, but this was eliminated after controlling for thickness and the other significant variables.
Since the two categorical factors, sex and presence/absence of ulceration, were the two most important risk factors after correcting for tumour thickness, and since a similar approach proved effective in analysis of the whole of the SMG database , a separate stepwise proportional hazards analysis was performed for each of the four sex-ulceration subgroups (i.e. females with ulcerated lesions, females with non-ulcerated lesions, males with ulcerated lesions, and males with non-ulcerated lesions). Once divided into these groups, only the tumour thickness had any further prognostic effect, i.e. the interactions between sex, ulceration and tumour thickness eliminated the effect of level of invasion demonstrated in the simpler stepwise analysis. The survival profiles for the four sex/ulceration subgroups clearly demonstrated that increasing tumour thickness reduced survival prospects in all four groups, the worst prognosis being in men with thick ulcerated melanomas.
Discussion
This study is one of the largest analyses of invasive head and neck melanoma reported, and is the most complete study based on a geographically defined population rather than an institutional series. It is also notable in covering patients living in a temperate climate; with few exceptions (Ringborg et al., 1993; Andersson et al., 1993) other studies with a similar number of cases have been in areas of the world with much greater sunlight exposure. This may explain some of the differences in histogenetic types and anatomical sites of melanoma between the present study and other reported series.
Despite having excluded lentigo maligna/LMM in situ, which mainly occur on the face, and all other in situ melanomas, the proportion of malignant melanomas arising on the head and neck in the present study (21% of the total Scottish Melanoma Group database) is higher than the 11 -17% reported in other large studies (Sober et al., 1980; Gussack et al., 1983; Fisher, 1989; O'Brien et al., 1991; Langford et al., 1993) . Most striking is the high proportion of patients with LMM (52%), which is considerably greater than the 24% reported in a recent large European study (Ringborg et al., 1993) , and 15-16% in large Australian and American studies (Fisher, 1989 ; O'Brien et al., Langford et al., 1993) . These head and neck LMM accounted for 83% of all LMM registered with the SMG, a similar proportion to that reported by many authors (Conley and Pack, 1963; Sober et al., 1980; Blois et al., 1983) , although the reported proportion varies from 36% (Van der Esch, cited by McGovern et al., 1980) to 92% (McGovern et al., 1980) . The older age of patients with LMM in the present and other studies (McGovern et al., 1980; Holman and Armstrong, 1984; Langford et al., 1993; Ringborg et al., 1993) , is consistent with the theory that LMM is related more to cumulative lifetime sunlight exposure than the other varieties, which are postulated to be related to acute intermittent sunlight exposure (MacKie, 1981; Holman et al., 1983; Swerdlow, 1984; Elwood et al., 1987) . Depending on occupation and leisure interests, the head and neck may be exposed to sunlight in either of these patterns. However, the steady increase in all three main histogenetic subtypes of melanoma during the study period is not in support of different aetiologies (the sharp increase in SMM in 1985, shown in Figure 1 , is probably due to a Scottish melanoma educational campaign as registrations increased at all body sites in this year). Furthermore, personal factors identified as risk factors for lentigo maligna and lentigo maligna melanoma in a recent study (McHenry et al., 1995) are also recognised as risk factors for SSM and NM.
The results of the present study confirm our earlier report (Cox et al., 1987 ) of significant anatomical subsite differences between the sexes and for histogenetic types of melanoma. The overall distribution of melanoma at different subsites (face, scalp, ear and neck) is similar to other large series (Fisher, 1989; O'Brien et al., 1991; Ringborg et al., 1993) , and the male predominance of melanoma on the neck, scalp and ears also confirms results of other authors (Fitzpatrick et al., 1972; Knutson et al., 1972; Byers et al., 1980; Day et al., 1982a; Gussack et al., 1983; Fisher, 1989; O'Brien et al., 1991; Ringborg et al., 1993) . The reasons for this are uncertain but baldness and shorter hair styles in men are likely to be the explanation. Most studies of head and neck melanoma have reported a male predominance (Kragh and 943 Erich, 1960; Conley and Pack, 1963; Catlin, 1966; Ballantyne, 1970; Fitzpatrick et al., 1972; Knutson et al., 1972; Donellan et al., 1972; Simons, 1972; Ames et al., 1976; Gussack et al., 1983; Urist et al., 1984; Fisher, 1989; O'Brien et al., 1991) , although a few studies (McGovern et al., 1980; Wanebo et al., 1988; Ringborg et al., 1993; Andersson et al., 1993) support our finding an excess of females. Where data for other body sites is available from the same study population, the male-female ratio is higher for the head and neck than for other body sites (Hansen and McCarten, 1974; Ames et al., 1976; Gussack et al., 1983; Cox et al., 1987; Langford et al., 1993) and an absolute or relative excess of females with LMM is generally reported in studies where this has been analysed (McGovern et al., 1980; Cox et al., 1987; Ringborg et al., 1993) .
It is interesting to consider reasons for the differences between the Swedish Melanoma Group study (Ringborg et al., 1993 ) and the present report from a similar latitude. LMM was less frequent in that study (24% compared with our 52%), although the anatomical subsite and sex differences were similar to our results. In particular, LMM in the Swedish study was overrepresented in females (female-male ratio 2.4:1 compared with 1.1:1 for all sites in their study population), and the LMM prognosis was better. However, it is not stated whether the Swedish data include non-invasive LMM, which would clearly improve the prognosis for the LMM group, and unfortunately the authors felt that LMM was a separate entity and excluded it from the detailed analysis of survival.
Potential prognostic factors for melanoma that were analysed in the present study were those identified in large studies of melanoma at any site. Because there are many prognostic variables, which may all have individual significance, but which may be interrelated (e.g. thickness and depth of invasion), the stepwise analysis was used to identify the most important prognostic indicators. This demonstrated that male sex and presence of ulceration significantly worsened survival but confirmed the tumour thickness to be the most important factor, as determined in virtually all studies of melanoma. The survival profiles for the four sex/ulceration subgroups clearly demonstrated that increasing tumour thickness reduced survival prospects in all four groups. Ulceration is a significant predictive factor in many studies that have controlled for tumour thickness (Balch et al., 1978 (Balch et al., , 1980 Van der Esch, 1981; Day et al., 1982b; Urist et al., 1984; Shaw et al., 1985; O'Brien et al., 1991; Andersson et al., 1993; Langford et al., 1993; MacKie et al., 1995) and even retains significance in patients with lymph node metastasis (Balch et al., 1980) . Male sex has been associated with poorer prognosis in most studies of head and neck melanoma (Ballantyne, 1970; Fitzpatrick et al., 1972; Hansen and McCarten, 1974; Gussack et al., 1983; Cox et al., 1987; O'Brien et al., 1991; Langford et al., 1993; Ringborg et al., 1993; Andersson et al., 1993) , although some studies report no sex difference (Catlin, 1966; Knutson et al., 1972; McGovern et al., 1980) and one reported a better prognosis in men (Southwick et al., 1963) .
Several authors have identified melanoma of the head and neck as having a worse prognosis than other body sites (Day et al., 1982b; Blois et al., 1983; Gussack et al., 1983; Urist et al., 1984; Fisher, 1989; Hersey et al., 1991) , and some have identified subsite differences in prognosis for head and neck melanomas on univariate (Ballantyne, 1970) or multivariate (Urist et al., 1984; Wanebo et al., 1988; Fisher, 1989; O'Brien et al., 1991; Ringborg et al., 1993) analysis. In general, a worse prognosis has been reported for scalp (Urist et al., 1984; Wanebo et al., 1988; Fisher, 1989; O'Brien et al., 1991; Ringborg et al., 1993) or scalp and ear (Wanebo et al., 1988) . Despite the differences in sex of patients and histogenetic types of melanoma at different anatomical subsites, the site of melanoma did not have independent significance in the proportional hazards analysis in the present study.
LMM has been reported to have a better prognosis than other histogenetic types of melanoma, but this data is confounded both by inclusion of lentigo maligna (McGovern et al., 1980) and by failure to control for tumour thickness in older studies. Some studies using multivariate analyses do still report a better prognosis for this histogenetic type of melanoma (Urist et al., 1984; Wanebo et al., 1988; O'Brien et al., 1991) . However, other authors are in agreement with our conclusion that, thickness for thickness, LMM does not have a better prognosis than other types of melanoma once invasion has occurred and when sex and ulceration are taken into account (Gussack et al., 1983; Koh et al., 1984; Pittelkow et al., 1986; Langford et al., 1993) . The report by Urist et al. (1984) , which indicated that ulceration was a more important variable than thickness for LMM, is not supported by the present or most other studies, although ulceration is undoubtedly an important prognostic feature after accounting for tumour thickness. Our results clearly demonstrate that the most important prognostic variable for all histogenetic types of head and neck melanoma is the tumour thickness.
